Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 535.73 billion as of November 3, 2025. Its market cap has increased by 4.42% in one year.

Market Cap

535.73B

Enterprise Value

543.40B

Revenue

134.56B

Ranking

n/a

PE Ratio

71.08

Stock Price

1,890.35

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 535.73B, an increase of 46,513.46%. That is a compound annual growth rate of 28.61%.

Market Cap History

Date	Market Cap	% Change
Oct 31, 2025	533.70B	17.54%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	20.11T
HDFC Bank	15.17T
Bharti Airtel	12.32T
Tata Consultancy Services	11.06T
ICICI Bank	9.61T
State Bank of India	8.65T
Bajaj Finance	6.47T
Infosys	6.14T

Market Cap Rankings